Panagora Asset Management’s Foghorn Therapeutics FHTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $307K | Buy |
65,337
+11,002
| +20% | +$51.7K | ﹤0.01% | 926 |
|
2025
Q1 | $198K | Sell |
54,335
-819
| -1% | -$2.99K | ﹤0.01% | 1048 |
|
2024
Q4 | $260K | Buy |
55,154
+15,913
| +41% | +$75.1K | ﹤0.01% | 1000 |
|
2024
Q3 | $365K | Sell |
39,241
-59,286
| -60% | -$552K | ﹤0.01% | 995 |
|
2024
Q2 | $567K | Sell |
98,527
-1,778
| -2% | -$10.2K | ﹤0.01% | 882 |
|
2024
Q1 | $673K | Buy |
100,305
+3,288
| +3% | +$22.1K | ﹤0.01% | 909 |
|
2023
Q4 | $626K | Buy |
97,017
+62,441
| +181% | +$403K | ﹤0.01% | 940 |
|
2023
Q3 | $173K | Buy |
+34,576
| New | +$173K | ﹤0.01% | 1189 |
|